Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

1454GCC: Anti-PD-1 (MK-3475) and IMiD (Pomalidomide) Combination Immunotherapy in Relapsed/Refractory Multiple Myeloma

Ashraf Badros · 2014
ClinicalTrials.gov · Datasets · License: Public Domain · 2014
Open Source ↗
immunotherapymultiple-myeloma
multiple myeloma, relapsed/refractory, mk-3475 & pomalidomide, immunotherapy, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 918426
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.